When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 9 Hits
  • Search Condition : Filter (MeSH = Osteoporosis / drug therapy)
Species Resource
Mice CAT-RhoA DN/4-18 Suppression of bone formation by osteoclastic expression of semaphorin 4D.
DNA material AxCA Luc+ (RDB02453) Identification of dynamin-2-mediated endocytosis as a new target of osteoporosis drugs, bisphosphonates.
Human and Animal Cells MC3T3-E1(RCB1126) Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation.
Human and Animal Cells MC3T3-E1 (RCB1126) Olive polyphenol hydroxytyrosol prevents bone loss.
Human and Animal Cells RAW 264 (RCB0535) Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.
Human and Animal Cells MC3T3-E1 (RCB1126) G alpha(q) signal in osteoblasts is inhibitory to the osteoanabolic action of parathyroid hormone.
Human and Animal Cells RAW 264 (RCB0535) ST2 (RCB0224) Palmatine attenuates osteoclast differentiation and function through inhibition of receptor activator of nuclear factor-κb ligand expression in osteoblast cells.
Human and Animal Cells A novel member of the calcitonin gene-related peptide family, calcitonin receptor-stimulating peptide, inhibits the formation and activity of osteoclasts.
Human and Animal Cells MC3T3-E1(RCB1126) Antiosteoporotic Effects of Acer palmatum Extract on Osteoclastogenesis and Osteoblastogenesis.